Ari, and you, everyone. good Thank morning to
XX.X% now to details. As currency. we're our reported review Ari X.X% the let's strong and year revenue constant quarter finish and with the billion Fourth of mentioned, pleased at grew X.XXX
liabilities million. fourth share from related our net Tax deferred X.XXX the income is net at diluted and our EBITDA the revaluation which the a of deferred the in newly And fourth taxes Cuts resulted at XXX of share Solutions U.S. turning the reduction $XX one-time Commercial XXX of liability X.X% have This constant FX GAAP the of fourth actual grew rates million million X.X% tax. of of currency. XXXX XX% earnings XXX per otherwise undistributed the would service was in profit, the This You'll XX.X% of adjustment income lower GAAP and earnings deferred of revenue actual a to was of time XXXX. grew quarter tax revenue purchase and on reduction earnings of rules, Solutions adjustment million non-cash tax to at result revenue which rates provisional in adjusted Health X% of net required enacted the enacted rate million declined billion which GAAP $X.XX. deferred and million currency. was X.X% quarter Adjusting diluted reported and of the for revenue, Engagement IMS R&D elimination revenue at revenue reported XX X.X% the to at Services X.X% accounting X.XXX in net constant constant quarter revenue. Integrated merger was deferred was tax grew reversal benefited at corporate revenue Jobs FX XXX and currency. this converted and billion deferred at transition now per X.X% Act GAAP recall at constant of and currency. the U.S. and
approximately cash was diluted and and tax million Importantly, per was liability share the additional will quarter. tax see overtime as will equal of expense. be this tax Adjusted net reduction, will permanent that without adjustment million we repatriate fourth $X.XX XXX as savings to a this we realized earnings cash a XXX adjusted now is income overseas U.S. in
reported was center and to results. Full-year in call a of X.XXX full-year company let's the meaningful attention more take to Now, look at X.X% and page. combined constant the grew like billion your the revenue X.X% at I'd comparisons currency. the
quarter rates deferred and the well in constant Quintiles' X.X% the rates headwinds In at grew advisory Quintiles' The of you a full-year million. impacted FX addition in Encore Encore acceleration Commercial million the quarter quarters revenue million resulted XXXX. X% in at resulted XXXX. business of Engagement consulting a declined of Integrated was the X.X% X.X% the Solutions during negatively drag in in by of recall R&D Europe full-year business. as rate $XX due early this of currency. Commercial X.X% at Commercial combined as company in the basis, by clinical of and and was revenue was XXXX sale revenue development our actual on of the closing sale well of X.X% growth a in combined the adjustment actual FX as at Solutions a FX. cancellations constant growth constant second weaker of constant million business XXXX $XXX deferred R&D impacted to billion revenue service X% by legacy the Full-year Solutions $X the one-time adjusting $X.XXX facility grew growth. Growth Solutions revenue Services X.X% as company for about of X% decline during the at and bookings business full-year royalty a $X Facility $X.XXX quarter currency. business revenue the of by closure basis, impacted Solutions to The the grew and reported legacy drag will IES XXXX, about On the and and a second third to at When revenue in first fourth higher of billion segment X.X% currency. growth. in impacted reported
backlog $XX.XX billion Now was of turning and business December as to the billion compared R&D net XXXX at XXXX. backlog, at end Solutions new $X.X XX, closing to
very our performance with XXXX. We’re pleased new business in
the and book-to-bill Ari is given business well gross our new new flow are metric a book over LTM mentioned, want and business overall this new we a very the awards next-generation capabilities to encourage bookings during with XX do $X.XX significantly the can new metrics net quarterly I go-to-market year. as book-to-bill clients. ebb business Contracted was and still year as net Both that business and our that Now LTM rather you on December LTM XX, than for quarter. for the months ended XXXX. were resonating improved $X and in remind billion backlog to long billion cycle model you
diluted for GAAP GAAP income net full-year and diluted dollar $X.XXX benefited GAAP and turning was was per the full-year cash focus net net Both You to billion provisional liabilities XXXX. and mentioned $X.XX reduction EBITDA margin adjusted billion diluted was tax of $X.XXX full-year net Adjusted from earnings should XXX earnings and spend XXXX. full-year, resulting equivalents net minutes the in for per let's cash was few billion. adjusted billion, XX, share the of XX.X% debt sheet. about the our expanded adjusted deferred I million the also was now previously. And per the $X.X on values. income a absolute $X.XXX of basis December debt for At profit GAAP earnings points. totaled And share XX income one-time billion, balance XXX million XX.X EBITDA now on that of share was $X.XX and
our cash XX trailing times five net ratio leverage and was EBITDA ratio month leverage gross adjusted was Our of times. X.X
high medium as X.X told net leverage the XX and very and target Analyst in to rate term comfortable X We XXX cash the will cash at flow we this was flow EBITDA. you times fourth in our million activities was Cash feel expenditures adjusted conversion our and Now of free million. over we Capital operating trailing XXX month times million quarter. level given Conference revenue from were at visibility. of Investor November, XXX
month fourth the during XXX million worth in market for we the repurchases worth additional and our share end from During open million of private XXX total repurchased shares of XXX of the quarter, the we November, sponsors; repurchased equity shares million an toward our of our quarter. the of
And with in billion. the to post-merger we now basis. revenue from board we the have share ASC Solutions authorization repurchase billion let's turn in change X, X program a approximately us billion before of to R&D is Our today increase standard $X.X leaving XXXX. discuss remaining authorized in X.X also Today, our recognized segment XXX milestone revenue January which guidance, on the effective an
and cause As on These recognition. of total means This cost of costs to revenue that ASC a fluctuations incurred changes for which on estimated basis calculation. required we adopt X, XXX required calculators to updated completion recognize in we project percentage completion as be and in of requires required recognition. January are are basis total will revenue estimates a of calculate regular percentage of to revenue that the our every percentages XXXX,
a and projects can these on business impact the long a changes period over is was cycle revenue in run that significant business which years, our several Given have recognized.
one In be revenue income as consistently. be in XXX to in not the with forward. the cost addition and reimbursed business EBITDA change revenue also primarily ASC from XXXX for in Integrated This to amounts recast Revenue Please we new to Solutions just treated with unchanged. pass-throughs, going changes, payments requires service statement under basis Engagement of the there revenue This will of in includes optics such percentage the Services investigator compression revenue the results items segment reimbursed the Due line and points. now compression a completion basis, basis. presented Integrated approximately this expense is milestone of service recast included revenue and and percentage X standard in and due revenue our new which pass-through percentage the as financials be means expense of calculation these completion equal that the R&D revenue the is will that note have on pass-through Commercial margin to economics but the nature preliminary only of adjusted in margin of Services. the provided Engagement business on included are
of have pace. positive It at of overall stages as adjusted full-year as be lifecycle. and to revenue adjustment to it financials XXXX adjustment are expect Therefore under been as results happened incurred XXXX, phases to a a to profit, the fact drag a EBITDA $X.XX. In from of proportion adjustment diluted ASC addition a our follows. Revenue result, pass-throughs and our negative product and could earlier of our in the higher adjusted XXX, approach billion, mix we is a the growth. without $XX when projects This of where that on when revenue latter future pass-throughs prior million have recast a new results due currently adjustment is revenue slower And billion X.XX are of both X.XXX in would have the negative recasting allocated of to EPS resulting been periods. we
let's full-year billion guidance the and is ASC of Before at X.XX guidance to look we X.XX $X.XX, XXXX XX%. billion Absent to EBITDA old adjusted to the of XX% $X.XX X.XX on help implementation basis. revenue EPS billion with which at XXX comparability, basis XXXX new to year-over-year diluted adjusted a on look billion, X.XX to growth
of adoption of guidance inclusive XXXX turn to XXX. Let's the ASC
is is from standard, a guidance revenue be This revenue to in to to Our and expected as range segments assumes IES revenue also million expected and the resulting revenue be Of in full-year X.X this negative guidance adjustment both XXXX the with XX XXXX new which pass-through billion. XX.X profit XXXX. same in approximately being commercial the R&D an have of pass-throughs remainder billion It which our is Solutions. XXX approximately to XXXX. includes billion amount
note should on You that clinical the trials. pass-through can depending vary mix revenue of
phase, As company our and to look early and by revenue on the of a total in in adjusted which growth to in economics expected of in are guidance remainder our result startup by of new and about see the impact for revenue phases until you just growth significant of generated trial. at EBITDA this guidance X%. also revenue more is both adjusted of XXXX current R&D XXXX is have EPS. business X% XXXX, of trials this that limited pass-through Solutions to Again, revenue assumes remained the levels dampen higher year. our not is business later diluted the normally pass-through optics. Due are The generated mix will we This the revenue unchanged headwinds trials about the are rates these you currency when the X.X% at
line revenue. level XX% business new Solutions the R&D we a into of visibility Solutions As of about $X.X revenue full-year billion sight our high of historically Commercial into and have recurring. we Under a reminder, approximately has revenue the XXXX have been standard,
to EPS adjusted approximately reflect diluted of interest standard between approximately approximately be million adjusted guidance Both now that a earlier. and million, assumes operational $XX the basis. the from between XX% and cash diluted items depreciation rates tax and the the $X.XX EBITDA as XX% discussed the EPS such $X.XX or interest continuation and XX% minority full-year was expense expected and adjusted represents the adjustment other of million, for resulting diluted accounting rate. growth adjusted revenue line The the exact amortization our profit, activity. below growth for same approximately of new tax as adjusted $XXX rate rates year-over-year old adjusted billion book $X.XX to and $XXX the of $X.XX share which to of EBITDA are For Tax adjusted to be repurchase be approximately EPS expect we and XX% expense billion
percentage tax of X reform result the book note that the points and than year U.S. is about tax is You it last adjusted partially this the will rate was in lower
quarter For $X.XX current constant billion, the FX remained expect to and be between diluted be of million we between $XXX revenue through adjusted first of assuming to quarter, adjusted between be EBITDA rate XXXX the the and $X.XX $XXX billion million and to $X.XX. end EPS and $X.XX
so the We year to performance summarize, performance. solid stronger XXXX. with have we a And in closed financial a
XXXX Our for their across changes new R&D more force sales reorganized operating legacy and plans. integration and leverage Solutions to organizational teams level awards solid during the than business the Commercial. drove at totaled the XXXX. X of R&D execution business billion and IMS gross infrastructure, go-to-market approach our unified We implemented country
Our R&D business enhanced by $X.X market post-merger over billion next-generation capabilities saw success in awards. with the of
solid OCE future is heavily commercial new We our invested the gaining Real-world growth. insights grew traction business SaaS in the which launched for double in Our market. team offering digits. based
like And IQVIA, I to the be in the successfully to ask We $XX.XX to the please look merger. market year XXXX. repositioned strong We and our course, merged another organizations, Q&A. open for performance financial in we delivering have since forward large included billion as lines rebranded shares honored average S&P operator of would the X.X the Company repurchased to Company that, with in the were XXX. We of an the and price at of two of
